NasdaqGM - Delayed Quote • USD
Revance Therapeutics, Inc. (RVNC)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 343,079 | 10 |
| Sales | 29,089 | 4 |
| Net Shares Purchased (Sold) | 313,990 | 14 |
| Total Insider Shares Held | 7.47M | -- |
| % Net Shares Purchased (Sold) | 4.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| JORDAN ERICA Officer | Sale at price 3.80 per share. | Direct | 9,096 | Apr 16, 2024 |
| SCHILKE TOBIN C Chief Financial Officer | Sale at price 5.04 per share. | Direct | 47,204 | Mar 18, 2024 |
| SJUTS DUSTIN S President | Sale at price 5.04 per share. | Direct | 46,446 | Mar 18, 2024 |
| MOXIE DWIGHT General Counsel | Sale at price 5.04 per share. | Direct | 40,971 | Mar 18, 2024 |
| FOLEY MARK J Chief Executive Officer | Purchase at price 6.98 per share. | Direct | 209,400 | Mar 6, 2024 |
| FOLEY MARK J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 29, 2024 |
| SCHILKE TOBIN C Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 29, 2024 |
| SJUTS DUSTIN S President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 29, 2024 |
| MOXIE DWIGHT General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 29, 2024 |
| SCHILKE TOBIN C Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| MOXIE DWIGHT General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
| FOLEY MARK J Chief Executive Officer | Stock Award(Grant) at price 7.47 per share. | Direct | 1,972 | Dec 29, 2023 |
| SCHILKE TOBIN C Chief Financial Officer | Stock Award(Grant) at price 7.47 per share. | Direct | 3,242 | Dec 29, 2023 |
| SJUTS DUSTIN S President | Stock Award(Grant) at price 7.47 per share. | Direct | 1,972 | Dec 29, 2023 |
| MOXIE DWIGHT General Counsel | Sale at price 17.06 - 17.81 per share. | Direct | 612,624 | Sep 6, 2023 |
| FOLEY MARK J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| SCHILKE TOBIN C Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| SJUTS DUSTIN S President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| MOXIE DWIGHT General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 11, 2023 |
| FOLEY MARK J Chief Executive Officer | Sale at price 22.57 per share. | Direct | 593,151 | Aug 3, 2023 |
| FOLEY MARK J Chief Executive Officer | Sale at price 24.94 per share. | Direct | 655,333 | Jul 3, 2023 |
| SCHILKE TOBIN C Chief Financial Officer | Sale at price 25.04 per share. | Direct | 42,593 | Jul 3, 2023 |
| FOLEY MARK J Chief Executive Officer | Stock Award(Grant) at price 25.31 per share. | Direct | 25,310 | Jun 30, 2023 |
| SCHILKE TOBIN C Chief Financial Officer | Stock Award(Grant) at price 25.31 per share. | Direct | 19,463 | Jun 30, 2023 |
| SJUTS DUSTIN S President | Stock Award(Grant) at price 25.31 per share. | Direct | 25,310 | Jun 30, 2023 |
| KOLAJA CAREY O CONNOR Director | Sale at price 28.24 per share. | Direct | 70,600 | Jun 15, 2023 |
| KOLAJA CAREY O CONNOR Director | Conversion of Exercise of derivative security at price 18.12 per share. | Direct | 45,300 | Jun 15, 2023 |
| FOLEY MARK J Chief Executive Officer | Sale at price 30.72 per share. | Direct | 960,928 | Jun 9, 2023 |
| SJUTS DUSTIN S President | Sale at price 30.82 per share. | Direct | 154,096 | Jun 9, 2023 |
| SCHILKE TOBIN C Chief Financial Officer | Sale at price 30.57 - 31.00 per share. | Direct | 98,070 | Jun 2, 2023 |
| FOLEY MARK J Chief Executive Officer | Sale at price 34.55 per share. | Direct | 2,433,725 | May 15, 2023 |
| SCHILKE TOBIN C Chief Financial Officer | Sale at price 34.55 per share. | Direct | 739,338 | May 15, 2023 |
| SJUTS DUSTIN S President | Sale at price 34.55 per share. | Direct | 726,003 | May 15, 2023 |
| MOXIE DWIGHT General Counsel | Sale at price 34.55 per share. | Direct | 739,338 | May 15, 2023 |
| GANGOLLI JULIAN S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2023 |
| RUSSELL ANGUS CHARLES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2023 |
| BERAUD JILL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2023 |
| WARE OLIVIA C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2023 |
| CORIC VLADIMIR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2023 |
| NOLET CHRIS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2023 |
| KOLAJA CAREY O CONNOR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 3, 2023 |
| SCHILKE TOBIN C Chief Financial Officer | Sale at price 31.70 per share. | Direct | 101,472 | May 1, 2023 |
| SCHILKE TOBIN C Chief Financial Officer | Sale at price 32.15 per share. | Direct | 102,912 | Apr 3, 2023 |
| FOLEY MARK J Chief Executive Officer | Sale at price 31.59 per share. | Direct | 2,223,360 | Mar 9, 2023 |
| SCHILKE TOBIN C Chief Financial Officer | Sale at price 31.59 per share. | Direct | 584,884 | Mar 9, 2023 |
| SJUTS DUSTIN S President | Sale at price 31.59 per share. | Direct | 679,358 | Mar 9, 2023 |
| MOXIE DWIGHT General Counsel | Sale at price 31.59 per share. | Direct | 584,220 | Mar 9, 2023 |
| SCHILKE TOBIN C Chief Financial Officer | Sale at price 33.50 per share. | Direct | 107,234 | Mar 1, 2023 |
| CORIC VLADIMIR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2023 |
| SCHILKE TOBIN C Chief Financial Officer | Sale at price 34.60 per share. | Direct | 110,755 | Feb 1, 2023 |
Related Tickers
AMLX Amylyx Pharmaceuticals, Inc.
1.7600
-1.12%
DAWN Day One Biopharmaceuticals, Inc.
14.92
+12.94%
FATE Fate Therapeutics, Inc.
3.8000
-1.81%
SAGE Sage Therapeutics, Inc.
13.69
+0.81%
KPTI Karyopharm Therapeutics Inc.
1.0600
0.00%
ARQT Arcutis Biotherapeutics, Inc.
8.47
-1.40%
PTCT PTC Therapeutics, Inc.
28.57
+12.08%
ABEO Abeona Therapeutics Inc.
3.2600
+2.19%
TSVT 2seventy bio, Inc.
4.2550
-0.82%
TVTX Travere Therapeutics, Inc.
5.26
-2.41%